Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2018-08-24
Original SEC Filing: Click here

---

Webplus: BSPM/20180824/8-K/2_EX-99.1/000.htm SEC Original: ex_122718.htm
Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq XIANYANG, China, August 23, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (the “Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on August 16, 2018, it received a notification letter from Nasdaq Listing Qualifications (“Nasdaq”) advising the Company that, since it

---

---

Webplus: BSPM/20180824/8-K/1/000.htm SEC Original: biostar20180824_8k.htm
FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): August 16 , 2018 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xiangyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) Emerging growth

---

Company Info:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2018-08-24CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046